Edwards Lifesciences

-$0.24 (-0.21%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care.

CEO
Michael A. Mussallem
Employees
14,900
Headquarters
Irvine, California
Founded
1958

EW Key Statistics

Market Cap
71.35B
Price-Earnings Ratio
49.48
Dividend Yield
—
Average Volume
2.29M
High Today
$114.98
Low Today
$113.57
Open Price
$114.73
Volume
2.08M
52 Week High
$114.99
52 Week Low
$70.92

EW News

BenzingaAug 2

Expert Ratings for Edwards Lifesciences - Edwards Lifesciences Corp.

Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bul
Simply Wall StJul 31

Does Edwards Lifesciences Deserve A Spot On Your Watchlist?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling short, can easily find investors. But as
Simply Wall StJul 31

Here's Why We Think Edwards Lifesciences Is Well Worth Watching

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those business

EW Earnings

$0.17
$0.62
$1.06
$1.51
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$0.55 per share
Actual
$0.64 per share
Replay Earnings Call

More EW News

BenzingaJul 30

Analyzing Edwards Lifesciences's Unusual Options Activity - Edwards Lifesciences Corp.

Shares of Edwards Lifesciences (NYSE:EW) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved down to $111.6.
MarketWatchJul 29

Edwards Lifesciences posts Q2 profit, points to recovery signs

Edwards Lifesciences Corp. swung to a profit in the latest quarter with sales up 49% from last year, when the pandemic caused a drop in procedures. The medical
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure